REQUEST A DEMO
Total
USD $0.00
Search more companies

Brego Life Sciences Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Brego Life Sciences Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Brego Life Sciences Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Kuala Lumpur. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on December 01, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 69.61% in 2022. Over the same period, its total assets grew by 50.61%. In 2022, Brego Life Sciences Sdn. Bhd.’s net profit margin increased by 3.37%.

Headquarters
No. 5, Jalan Manis 6, Taman Segar, Cheras
Kuala Lumpur; Federal Territories; Postal Code: 56100

Contact Details: Purchase the Brego Life Sciences Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Brego Life Sciences Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Brego Life Sciences Sdn. Bhd. report to view the information.
Incorporation Date:
December 01, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Brego Life Sciences Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
69.61%
Total operating revenue
69.61%
Operating profit (EBIT)
104.81%
EBITDA
104.57%
Net Profit (Loss) for the Period
105.02%
Total assets
50.61%
Total equity
102.77%
Operating Profit Margin (ROS)
4.39%
Net Profit Margin
3.37%
Return on Equity (ROE)
0.61%
Debt to Equity Ratio
-29.86%
Quick Ratio
2.99%
Cash Ratio
0.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?